
Sanofi Pasteur MSD appoint president of Vaccines Europe
pharmafile | January 16, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â Andrea Rappagliosi, Sanofi pasteur msd, vaccinesÂ
Vice president of Market Access, Health Policy & Medical Affairs at Sanofi Pasteur MSD Andrea Rappagliosi has been appointed president of Vaccines Europe.
Vaccines Europe is the group representing vaccine manufacturers within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional association of the European pharmaceutical industry.
Its members include established vaccine firms such as AstraZeneca, Sanofi Pasteur, Novartis, GlaxoSmithKline Biologicals, Pfizer, Crucell, Abbott, Baxter and MSD.
Sanofi Pasteur MSD is one of the largest vaccines companies in Europe and Rappagliosi will join the new management team brought together by Jean Paul Kress, president of Sanofi Pasteur MSD, since he took over the company in 2011.
“I am strongly supportive of Andrea’s presidency as it reflects our commitment to maintain and strengthen healthcare excellence in Europe for the benefit of people’s health and wellbeing” said Kress.
With 20 years of experience in the pharma industry and a number of years within the Italian Institutions, Rappagliosi joined Sanofi Pasteur MSD from GlaxoSmithKline in 2012 as vice president of Market Access, Health Policy & Medical Affairs.
Related Content
Valneva Scotland supports local cancer charity Team Jak FoundationÂ
Valneva Scotland, the country’s largest vaccine producer, has partnered with local West Lothian-headquartered charity, Team …

Pfizer releases results for severe RSV-associated LRTD treatment study
US-based Pfizer have announced results from its substudy B of the ongoing phase 3 clinical …

Merck plans to conduct trials for HPV vaccines
Merck, known as MSD outside of the US and Canada, has announced that it is …






